| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.2 | 4e-06 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-06 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |